Cure My Disease

Don't miss your cure!

 Log in / Sign up

New implant aims to stop sleep apnea episodes

NCT ID NCT06556693

Recruiting now Disease control Sponsor: Zoll Medical Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new implantable device called the Remede Dual Channel System for people with severe sleep apnea. The device is designed to stimulate nerves to keep the airway open during sleep. Researchers will check if the implant is safe and if it can reduce breathing pauses during sleep. The study involves 40 participants and will follow them for 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
implantable dual channel stimulation device
What this could lead to
If successful, this device could offer a new treatment option for people with severe sleep apnea who cannot use standard therapies.
What could go wrong
This is an early feasibility study with only 40 people, so results may not apply to everyone. The implant procedure carries risks like infection or nerve injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP APNEA

Contacts and locations

Locations

  • The Insomnia and Sleep Institute of Arizona LLC

    RECRUITING

    Scottsdale, Arizona, 85255, United States

    Contact Email: •••••@•••••

  • The Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

  • The University of Michigan Health-West

    RECRUITING

    Wyoming, Michigan, 49519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.